Pfizer’s investigational atopic dermatitis treatment receives EAMS positive scientific opinion from the UK MHRA
Feb 10, 2021
Get email alerts for when the next magazine and online PDF issue is available.
You have reached your entry limit for today. Please contact our team if you have any queries.